132 results
Page 3 of 7
8-K/A
EX-99.1
3qimh76zzcktv6zoen
26 Jun 20
Other Events
5:08pm
8-K/A
EX-99.4
o5owiynq7w24pz9b
26 Jun 20
Other Events
5:08pm
8-K/A
EX-99.2
lcyo l7pj1
26 Jun 20
Other Events
5:08pm
8-K/A
EX-99.3
0hta4 e08m6k84
26 Jun 20
Other Events
5:08pm
8-K/A
EX-99.5
kmvc4z
26 Jun 20
Other Events
5:08pm
D
rtx1k4yea9x mf
10 Jun 20
$82.08M in equity, sold $82.08M, 1 investor
1:02pm
D
n5a3hb
10 Jun 20
$80M in equity / securities to be acquired, sold $80M, 24 investors
12:57pm
8-K
EX-10.1
6jfx7t9taxl 9gm87i48
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.3
uji1ikv708
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-4.1
zh4j3 343jo
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.4
acz 11fnnu
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFA14A
aypkthj6wm2l
18 May 20
Additional proxy soliciting materials
9:55pm
DEFM14A
6vrsvbeycmdr
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
jn8 gb8r5
10 Apr 20
Preliminary revised proxy
4:38pm
8-K
2cduu7nv
9 Mar 20
Entry into a Material Definitive Agreement
12:00am
DEFA14A
h1pa9048f
9 Mar 20
Additional proxy soliciting materials
12:00am
PREM14A
v6np6rb
6 Mar 20
Preliminary proxy related to merger
5:32pm